Energy News / Shareholders Foundation, Inc.

OTCQB:BBLG Shareholder Notice: Lawsuit Alleges Misleading Statements by Bone Biologics

Via: ReleaseWire

Updated 12:15 PM CDT, Mon, July 22,2019

A lawsuit was filed on behalf of investors in Bone Biologics Corporation (OTCQB: BBLG) shares over alleged securities laws violations.

San Diego, CA -- (SBWIRE) -- 07/22/2019 -- An investor, who purchased shares of Bone Biologics Corporation (OTCQB: BBLG), filed a lawsuit over alleged violations of Federal Securities Laws by Bone Biologics Corporation.

Investors who purchased shares of Bone Biologics Corporation (OTCQB: BBLG) have certain options and for certain investors are short and strict deadlines running. Deadline: August 19, 2019. OTCQB: BBLG investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Bone Biologics Corporation was founded to pursue regenerative medicine for bone and is reportedly undertaking groundbreaking work and building on unprecedented research on the NELL-1 molecule that has produced a significant number of studies and publications in peer-reviewed scientific literature. Bone Biologics Corporation is reportedly currently focusing its development efforts for its bone graft substitute product on bone regeneration in spinal fusion. NELL-1 is a recombinant human protein growth factor that is essential for normal bone development.

The complaint charges Bone Biologics Corporation and certain of its officers and directors and officers with violations of Section 14(c) of the Securities Exchange Act of 1934 and Rule 14c-6, as well as other state law causes of action including breach of fiduciary duty by the Bone Biologics Corporation's directors and controlling stockholders, in connection with the Transaction. Section 14(c) of the Securities Exchange Act of 1934 and Rule 14c-6, generally prohibits filing information statements with the SEC containing information that's false or misleading with respect to any material fact or has any materially false or misleading omissions.

Those who purchased shares of Bone Biologics Corporation (OTCQB: BBLG) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/otcqbbblg-shareholder-notice-lawsuit-alleges-misleading-statements-bone-1248726.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com